G M Anantharamaiah Selected Research

Infections

11/2004	D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
9/2003	Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
8/2002	Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G M Anantharamaiah Research Topics

Disease

45	Atherosclerosis 01/2022 - 09/2000
24	Inflammation (Inflammations) 01/2021 - 11/2004
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 09/2000
5	Neoplasms (Cancer) 01/2024 - 11/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 02/2006
4	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2013
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2009
4	Vascular Diseases (Vascular Disease) 10/2015 - 08/2004
4	Human Influenza (Influenza) 11/2008 - 08/2002
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 09/2007
3	Sepsis (Septicemia) 01/2013 - 08/2009
3	Cognitive Dysfunction 11/2008 - 10/2006
3	Infections 11/2004 - 08/2002
2	Insulin Resistance 01/2021 - 01/2009
2	Myocardial Infarction 05/2020 - 09/2016
2	Endotoxemia 01/2013 - 08/2005
2	Hyperlipidemias (Hyperlipidemia) 12/2011 - 02/2002
2	Ovarian Neoplasms (Ovarian Cancer) 04/2011 - 11/2010
2	Atherosclerotic Plaque (Atheroma) 03/2011 - 12/2004
2	Vascular System Injuries 01/2009 - 08/2004
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2009 - 11/2008
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2019
1	Proteinuria 01/2019
1	Macular Degeneration (Age-Related Maculopathy) 01/2018
1	Reperfusion Injury 09/2016
1	Infarction (Infarctions) 09/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014
1	Body Weight (Weight, Body) 04/2013
1	Neuroinflammatory Diseases 01/2013
1	Amyloid Plaque 01/2013
1	Acute Lung Injury 01/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013
1	Ovarian Epithelial Carcinoma 03/2012
1	Adenocarcinoma 11/2010

Drug/Important Bio-Agent (IBA)

47	Peptides (Polypeptides)IBA 01/2024 - 04/2001
35	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2020 - 03/2001
14	LipidsIBA 01/2022 - 09/2000
14	ApolipoproteinsIBA 01/2021 - 06/2004
12	Apolipoproteins E (ApoE)IBA 01/2019 - 02/2002
12	CholesterolIBA 01/2018 - 01/2002
12	HDL LipoproteinsIBA 09/2016 - 03/2001
10	LDL Receptors (LDL Receptor)IBA 04/2015 - 08/2002
9	Lipoproteins (Lipoprotein)IBA 01/2021 - 04/2001
7	HDL CholesterolIBA 01/2021 - 08/2002
6	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016 - 06/2004
6	lysophosphatidic acidIBA 04/2015 - 11/2010
6	Amino Acids FDA Link 01/2009 - 07/2001
5	oxidized low density lipoproteinIBA 10/2017 - 09/2000
5	apolipoprotein A-I mimetic peptide 4FIBA 12/2011 - 08/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 10/2006
4	LipopolysaccharidesIBA 10/2014 - 12/2011
4	AntioxidantsIBA 03/2012 - 10/2004
3	EndotoxinsIBA 11/2019 - 12/2011
3	Triglycerides (Triacylglycerol)IBA 08/2015 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 08/2009 - 03/2006
3	Aryldialkylphosphatase (Paraoxonase)IBA 09/2005 - 08/2002
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 06/2009
2	Ac-hE18A-NH(2)IBA 03/2013 - 12/2011
2	EnzymesIBA 03/2012 - 01/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2006 - 06/2004
2	LDL Lipoproteins (beta Lipoproteins)IBA 07/2005 - 06/2004
2	Interleukin-6 (Interleukin 6)IBA 09/2003 - 08/2002
2	LDL CholesterolIBA 09/2003 - 08/2002
1	lipoxin A4IBA 11/2019
1	Interleukin-10 (Interleukin 10)IBA 11/2019
1	CholatesIBA 11/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2019
1	Piroxicam (Feldene)FDA LinkGeneric 11/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Immunotoxins (Immunotoxin)IBA 01/2019
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2016
1	Phosphotransferases (Kinase)IBA 09/2016
1	peptide 18AIBA 01/2016
1	6F peptideIBA 08/2015
1	PowdersIBA 08/2015
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 04/2015
1	6- (3- (piperazin- 1- yl)propanoyl)benzo(d)oxazol- 2(3H)- oneIBA 04/2015
1	mR18L peptideIBA 07/2013
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 04/2013
1	L-4F peptideIBA 01/2013
1	Small Interfering RNA (siRNA)IBA 03/2012
1	Linoleic AcidsIBA 03/2012
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 12/2011
1	LigandsIBA 12/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011
1	CarcinogensIBA 04/2011
1	SolventsIBA 03/2011
1	Cisplatin (Platino)FDA LinkGeneric 11/2010
1	Antineoplastic Agents (Antineoplastics)IBA 11/2010
1	Amyloid beta-PeptidesIBA 06/2009
1	Pravastatin (Pravachol)FDA LinkGeneric 06/2009

Therapy/Procedure

8	Therapeutics 01/2021 - 09/2007
3	Oral Administration 08/2006 - 01/2002
1	Percutaneous Coronary Intervention 09/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2016
1	Punctures 08/2009
1	Ligation 08/2009
1	Intraperitoneal Injections 08/2009